Retraction Note to: Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway

Mingjun Yu^{1

2

3}, Yixue Xue^{4

5

6}, Jian Zheng^{1

2

3}, Xiaobai Liu^{1

2

3}, Hai Yu^{1

2

3}, Libo Liu^{4

5

6}, Zhen Li^{1

2

3}, Yunhui Liu^{7

8

9}

Affiliations

¹ Department of Neurosurgery, Shengjing Hospital of China Medical University, 110004, Shenyang, People's Republic of China.
² Liaoning Clinical Medical Research Center in Nervous System Disease, 110004, Shenyang, People's Republic of China.
³ Key Laboratory of Neuro-oncology in Liaoning Province, 110004, Shenyang, People's Republic of China.
⁴ Department of Neurobiology, College of Basic Medicine, China Medical University, 110122, Shenyang, People's Republic of China.
⁵ Key Laboratory of Cell Biology, Ministry of Public Health of China, China Medical University, 110122, Shenyang, People's Republic of China.
⁶ Key Laboratory of Medical Cell Biology, Ministry of Education of China, China Medical University, 110122, Shenyang, People's Republic of China.
⁷ Department of Neurosurgery, Shengjing Hospital of China Medical University, 110004, Shenyang, People's Republic of China. liuyh_cmuns@163.com.
⁸ Liaoning Clinical Medical Research Center in Nervous System Disease, 110004, Shenyang, People's Republic of China. liuyh_cmuns@163.com.
⁹ Key Laboratory of Neuro-oncology in Liaoning Province, 110004, Shenyang, People's Republic of China. liuyh_cmuns@163.com.

PMID: 36175912
PMCID: PMC9523928
DOI: 10.1186/s12943-022-01660-3

Retraction Note to: Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway

Mingjun Yu et al. Mol Cancer. 2022.

. 2022 Sep 29;21(1):188.

doi: 10.1186/s12943-022-01660-3.

Authors

Mingjun Yu^{1

2

3}, Yixue Xue^{4

5

6}, Jian Zheng^{1

2

3}, Xiaobai Liu^{1

2

3}, Hai Yu^{1

2

3}, Libo Liu^{4

5

6}, Zhen Li^{1

2

3}, Yunhui Liu^{7

8

9}

Affiliations

¹ Department of Neurosurgery, Shengjing Hospital of China Medical University, 110004, Shenyang, People's Republic of China.
² Liaoning Clinical Medical Research Center in Nervous System Disease, 110004, Shenyang, People's Republic of China.
³ Key Laboratory of Neuro-oncology in Liaoning Province, 110004, Shenyang, People's Republic of China.
⁴ Department of Neurobiology, College of Basic Medicine, China Medical University, 110122, Shenyang, People's Republic of China.
⁵ Key Laboratory of Cell Biology, Ministry of Public Health of China, China Medical University, 110122, Shenyang, People's Republic of China.
⁶ Key Laboratory of Medical Cell Biology, Ministry of Education of China, China Medical University, 110122, Shenyang, People's Republic of China.
⁷ Department of Neurosurgery, Shengjing Hospital of China Medical University, 110004, Shenyang, People's Republic of China. liuyh_cmuns@163.com.
⁸ Liaoning Clinical Medical Research Center in Nervous System Disease, 110004, Shenyang, People's Republic of China. liuyh_cmuns@163.com.
⁹ Key Laboratory of Neuro-oncology in Liaoning Province, 110004, Shenyang, People's Republic of China. liuyh_cmuns@163.com.

PMID: 36175912
PMCID: PMC9523928
DOI: 10.1186/s12943-022-01660-3

No abstract available

PubMed Disclaimer

Retraction of

Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway.
Yu M, Xue Y, Zheng J, Liu X, Yu H, Liu L, Li Z, Liu Y. Yu M, et al. Mol Cancer. 2017 Jun 26;16(1):110. doi: 10.1186/s12943-017-0677-9. Mol Cancer. 2017. Retraction in: Mol Cancer. 2022 Sep 29;21(1):188. doi: 10.1186/s12943-022-01660-3. PMID: 28651608 Free PMC article. Retracted.

Cited by

Osteoclast-derived exosomal miR-30a-3p promotes lead exposure-induced osteoporosis by triggering osteoblastic pyroptosis.
Gao Y, Zhang H, Jia Y, Chen Y, Wang L, Ding J, Wang W, Zhu B, Ouyang L, He X, An Y, Yu T, Zhang H, Xu M. Gao Y, et al. Clin Sci (Lond). 2025 Apr 10;139(7):389-410. doi: 10.1042/CS20243438. Clin Sci (Lond). 2025. PMID: 40110632 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Retraction Note to: Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway

Affiliations

Retraction Note to: Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway

Authors

Affiliations

Retraction of

Similar articles

Cited by

Publication types

LinkOut - more resources

Full Text Sources